https://www.globenewswire.com/news-release/2023/11/22/2784967/0/it/essilorluxottica-e-moncler-annunciano-un-accordo-di-licenza-esclusiva.htmlhttps://www.globenewswire.com/news-release/2023/11/20/2783036/0/it/netbet-italia-e-elk-studios-uniscono-le-loro-forze.htmlhttps://www.globenewswire.com/news-release/2023/11/20/2782928/0/it/pine-investments-gmbh-offerta-di-acquisto-ai-titolari-di-sfp-di-astaris-s-p-a-astaldi-s-p-a-it0005422925.htmlhttps://www.globenewswire.com/news-release/2023/11/17/2782434/0/it/scopri-un-tesoro-di-risparmi-sui-più-diffusi-prodotti-per-la-casa-intelligente-gli-incredibili-e-tanto-attesi-sconti-per-il-black-friday-di-ezviz-sono-finalmente-live.htmlhttps://www.globenewswire.com/news-release/2023/11/16/2782316/0/it/pubmatic-rafforza-la-sua-impronta-globale-con-la-nomina-di-franck-lewkowicz-a-country-manager-per-la-francia.htmlhttps://www.globenewswire.com/news-release/2023/11/16/2782022/0/it/la-soluzione-acrow-riduce-al-minimo-l-interruzione-della-viabilità-durante-il-restauro-di-un-antico-ponte-alle-porte-di-vicenza.htmlhttps://www.globenewswire.com/news-release/2023/11/16/2781628/0/it/netbet-italia-e-blueprint-annunciano-una-partnership.htmlhttps://www.globenewswire.com/news-release/2023/11/14/2779990/0/it/sapere-come-gestire-e-prevenire-il-diabete-per-una-vita-migliore.htmlhttps://www.globenewswire.com/news-release/2023/11/13/2778872/0/it/il-dave-cantin-group-annuncia-l-investimento-di-kaltroco-che-alimenta-la-continua-crescita-della-società-di-consulenza-di-m-a-leader-nel-settore-automobilistico.htmlhttps://www.globenewswire.com/news-release/2023/11/10/2778531/0/it/egain-vince-il-premio-km-promise-della-rivista-kmworld-per-il-2023.htmlhttps://www.globenewswire.com/news-release/2023/11/08/2776621/0/it/egain-è-stata-nominata-visionaria-del-gartner-magic-quadrant-edizione-2023-per-il-crm-customer-engagement-center.htmlhttps://www.globenewswire.com/news-release/2023/11/08/2776458/0/it/cnh-rafforza-l-offerta-di-trattori-compatti-ampliando-gli-accordi-con-ls-tractor.htmlhttps://www.globenewswire.com/news-release/2023/11/06/2773716/20739/it/ultragenyx-lancia-in-italia-evkeeza-evinacumab-concentrato-in-soluzione-per-infusione-per-il-trattamento-dell-ipercolesterolemia-familiare-omozigote-hofh.html